Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, is pleased to announce that Andrew Unitt is being appointed to the Board as a non-executive director with effect from 1 January 2022. Andrew […]
Synendos Therapeutics is thrilled to announce the formation of the Scientific Advisory Board composed of prominent scientists and clinicians with significant CNS expertise. Read more…
Synendos Therapeutics is thrilled to announce the formation of the Scientific Advisory Board composed of prominent scientists and clinicians with significant CNS expertise. Read more
DayOne focus on healthcare innovation driven by digital health solutions. Together with supporting partners, they define and deliver the Accelerator each year in a run that includes specific themes, such as value-based healthcare, patient-centered innovation, or diabetes & metabolism. DayOne 2022 edition is focused on pain management. Are you a startup with a creative solution […]
London, UK – 21 October 2021 – Leucid Bio (“Leucid” or the “Company”), a biotech company pioneering next-generation cell therapies for hard-to-treat cancers, today announces that it has successfully raised £11.5 million in a Series A financing round. The investment was led by Epidarex and new investor Vulpes Investment Management, with participation from new investors 2Invest […]
